Precigen, Inc. (PGEN)

Precigen, Inc. (PGEN) is a healthcare company (biotechnology) based in the United States. The share price is $4.26, down 1.05% on the day, which values the company at $1.53B. Price as of 17 Nov 2026, 19:28 UTC, from Yahoo Finance.

Key facts

Share price
$4.26−1.05% today
Market value
$1.53B
P/E ratio
38.7×last 12 months
Funk Score
11/100
Against its own history
Well above its usual priceusual price $1.07
200-week average
$2.4971% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Precigen, Inc. in more detail

PGEN trades at 38.7× its last twelve months' earnings, -19.3× next year's expected earnings, 9.7× sales. Measured against its own history, the price is 296% above what its usual multiples would imply ($1.07) — well above its usual price. It sits 71% above its 200-week average of $2.49.

Over the last five fiscal years Precigen, Inc. has compounded revenue -21.3% a year. Its Funk Score is 11 out of 100 (financial strength 2.9, profitability 0.2, growth 1.3, value 0.0, each out of 10).

Worth checking: Altman Z in the distress zone; Weak Piotroski score.

2 of the superinvestors tracked here hold PGEN, including Samantha McLemore (5.2% of the portfolio), Polen Capital team (0.1% of the portfolio).

Superinvestors holding PGEN

2 of the investors tracked here report a position in their latest 13F filing.

Precigen, Inc. (PGEN): questions and answers

What is PGEN's P/E ratio?

Precigen, Inc. trades at 38.7× its last twelve months' earnings and -19.3× next year's expected earnings.

What is Precigen, Inc.'s market cap?

Precigen, Inc. is valued at $1.53B at a share price of $4.26.

Is PGEN overvalued or undervalued?

Against its own history, PGEN is well above its usual price: the price is 296% above the $1.07 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is PGEN above its 200-week moving average?

Yes. PGEN is 70.9% above its 200-week average of $2.49. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Precigen, Inc. growing?

Over the last five fiscal years Precigen, Inc.'s revenue grew -21.3% a year; over ten years revenue grew -25.1% a year.

Does PGEN pay a dividend?

Precigen, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Precigen, Inc. (PGEN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PGEN

Underlying data: Yahoo Finance; company filings with the SEC.